Anemia as a new predictor of mortality in patients hospitalized with congestive heart failure;Anemia como nuevo predictor de la mortalidad de pacientes hospitalizados por insuficiencia cardíaca congestiva

Medicina Clinica

Volumn 125, Issue 17, 2005, Pages

  Grigorian Shamagian, Lilian ^a   Varela Román, Alfonso ^a   Mazón Ramos, Pilar ^a   Pedreira Pérez, Milagros ^a   Rigueiro Veloso, Pedro ^a   González Juanatey, José Ramón ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Anemia; Heart failure; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; NITRATE; SPIRONOLACTONE;

ADULT; AGED; ANEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SURVIVAL;

EID: 29044438996     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13081371     Document Type: Article

References (35)

1. Barrios Alonso V, Peña Pérez G, González-Juanatey JR, Alegría Ezquerra E, Lozano Vidal JV, Llisterri Caro JL, et al. Hipertensión arterial e insuficiencia cardiaca en las consultas de Atención Primaria y de Cardiología en España. Rev Clin Esp. 2003;203:334-42.
2. Rodríguez-Artalejo F, Banegas Banegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol. 2004;57:163-70.
3. Varela-Roman A, Grigorian Shamagian L, Barge E, Bastante P, Gil de la Peña M, González-Juanatey JR. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction: long term prognosis. Heart. 2005;91:489-94.
4. Permanyer Miralda G, Soriano N, Brotons C, Moral I, Pinar J, Cascant P, et al. Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardíaca en un hospital general. Rev Esp Cardiol. 2002;55:571-8.
5. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted Country, Minnesota in 1991. Circulation. 1998;98:2282-9.
6. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-402.
7. Urrutia A, Lupón J, González B, Parajón T, Altimir S, Coll R, et al. Anemia y parámetras relacionados en pacientes de una unidad de insuficiencia cardíaca multidisciplinaria. Med Clin (Barc). 2004;122:136-7.
8. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 2003;41:1933-9.
9. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-44.
10. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiiffner D, Hess OM, et al. The prevalence of anemia in chronic heart failure, Int J Cardiol. 2002;86:115-21.
11. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation. 2003;107:223-5.
12. Kosborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-9.
13. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-6.
14. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol. 2003;60 (Suppl 1):93-102.
15. Felker GM, Adams KF, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004;44:959-66.
16. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-62.
17. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol. 2003;92:625-8.
18. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101-13.
19. Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-60.
20. World Health Organization. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:3-37.
21. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53-61.
22. Harnett JD, Kent GM, Foley RN, Parfrey PS. Cardiac function and hematocrit level. Am J Kidney Dis. 1995;25:S3-S7.
23. Lupón J, Urrutia A, González B, Herreros J, Altimir S, Coll R, et al. Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardíaca. Rev Esp Cardiol. 2005;58:48-53.
24. Kannel W. Epidemiology and prevention of cardiac failure: Framingham study insights. Eur Heart J. 1987;8:23-6.
25. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775-80.
26. Mancini DM, Katz SD, Lamanca J, Hudaihed A, Androne AS. Effect of erithropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-9.
27. Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol. 1999;92:153-60.
28. Bolger AP, Haehling S, Doehner W, Poole-Wilson PA, Coats AJ, Anker SD. Anemia and inflammation in chronic heart failure. J Card Failure. 2003;9:33.
29. Volpe M, Tritto C, Testa U, Rao MA, Martucci R, Mirante A, et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 1994;74:468-73.
30. Hussein SJ, Jain R, Shlipak MG, Ansari M, Massie BM. Chronic heart failure is not an independent cause of anemia. J Card Failure. 2003;9:19.
31. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-9.
32. Wu CH, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-6.
33. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35:681-9.
34. Hillege HL, Girbes AR, De Kam PJ, Boomsma F, De Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203-10.
35. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584-90.